Dear Colleagues,
A new program solicitation (RFA-AI-21-021) is now available:
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)
Please see https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-021.html for details.
Earliest submission date: June 02, 2021 following standard due date outlined in the FOA until July 07, 2023.
For timely responses to your questions, please direct your email messages to:
-------------------------------------------------------------
From the Program Solicitation:
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the enhancement and/or sustainment of high-value data science research software to improve the acquisition, management, analysis, visualization, and dissemination of data and knowledge across the immune-mediated, and infectious-disease research continuum, aligned with the research mission of NIAID. This includes infectious diseases, emerging infections, or immune-mediated diseases that include allergy, autoimmunity, or immune reactions associated with transplantation.
As a part of the trans-NIAID data science program, this FOA focuses on enhancement and/or sustaining operations and improving the user experience and availability of existing, widely adopted informatics tools and resources. This contrasts with exploratory (R21) and early-stage (U01) development efforts to generate these tools and resources that are supported by the companion FOAs.
Estimated Number of Awards: NIAID intends to commit $1,800,000 in FY 2022 to fund up to 2 awards.